nach oben

Die Diabetologie

Erschienen in:

27.04.2022 | Diabetes mellitus | Leitthema

Stationäre Patienten mit der Nebendiagnose Diabetes mellitus: klinische Relevanz

verfasst von: Prof. Dr. med. Christian Jenssen, Dr. med. Cristine Pietsch

Erschienen in: Die Diabetologie | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Zusammenfassung

In deutschen Krankenhäusern werden jährlich etwa 3 Mio. Patienten mit Diabetes stationär behandelt, davon 93 % nicht wegen, sondern mit dieser Erkrankung. In einzelnen Fachabteilungen liegt bei bis zu 40 % der Patienten die Nebendiagnose Diabetes vor. Sie haben oft eine relevante Komorbidität und im Vergleich zu Krankenhauspatienten ohne Diabetes eine längere stationäre Verweildauer, entwickeln deutlich häufiger Komplikationen und müssen öfter kurzfristig wieder aufgenommen werden. In dieser Übersicht wird die klinische Relevanz der Nebendiagnose Diabetes mellitus für Krankenhauspatienten besprochen.

Arya S, Binney ZO, Khakharia A et al (2018) High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization. J Vasc Surg 67:217–228.e1PubMedCrossRef

Auzanneau M, Fritsche A, Icks A et al (2021) Diabetes in the hospital—a nationwide analysis of all hospitalized cases in Germany with and without diabetes, 2015–2017. Dtsch Arztebl Int 118:407–412. https://doi.org/10.3238/arztebl.m2021.0151CrossRefPubMedPubMedCentral

Baur DM, Klotsche J, Hamnvik OP et al (2011) Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort. Metabolism 60:1363–1371PubMedCrossRef

Ben Q, Xu M, Ning X et al (2011) Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer 47:1928–1937PubMedCrossRef

Capes SE, Hunt D, Malmberg K et al (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773–778PubMedCrossRef

Chang S, Jiang J (2018) Association of body mass index and the risk of new-onset diabetes after kidney transplantation: a meta-analysis. Transplant Proc 50:1316–1325PubMedCrossRef

Cicek M, Buckley J, Pearson-Stuttard J et al (2021) Characterizing multimorbidity from type 2 diabetes: insights from clustering approaches. Endocrinol Metab Clin North Am 50:531–558PubMedPubMedCentralCrossRef

Dhatariya K, Mustafa OG, Rayman G (2020) Safe care for people with diabetes in hospital. Clin Med 20:21–27CrossRef

Dreyer M, Gallwitz B, Kellerer M et al (2018) Positionspapier der Deutschen Diabetes Gesellschaft zur Therapie des Diabetes mellitus im Krankenhaus, 2. Aufl. Deutsche Diabetes Gesellschaft, Berlin

10.

Eckert I, Kumbier MCC, Silva FM et al (2021) Association of specialized enteral nutrition with glycemic control and clinical outcomes in critically ill patients: a meta-analysis of randomized controlled trials. Clin Nutr 40:3940–3949PubMedCrossRef

11.

Einarson TR, Acs A, Ludwig C et al (2018) Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol 17:83PubMedPubMedCentralCrossRef

12.

Elena JW, Steplowski E, Yu K et al (2013) Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control 24:13–25PubMedCrossRef

13.

Gastaldelli A, Cusi K (2019) From NASH to diabetes and from diabetes to NASH: mechanisms and treatment options. JHEP Rep 1:312–328PubMedPubMedCentralCrossRef

14.

Ghosal S, Datta D, Sinha B (2021) A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D). Sci Rep 11:22063PubMedPubMedCentralCrossRef

15.

Goodarzi MO, Petrov MS, Andersen DK et al (2021) Diabetes in chronic pancreatitis: risk factors and natural history. Curr Opin Gastroenterol 37:526–531PubMedCrossRef

16.

Goodenough CJ, Liang MK, Nguyen MT et al (2015) Preoperative glycosylated hemoglobin and postoperative glucose together predict major complications after abdominal surgery. J Am Coll Surg 221:854–861.e1PubMedCrossRef

17.

Gosmanov AR, Umpierrez GE (2013) Management of hyperglycemia during enteral and parenteral nutrition therapy. Curr Diab Rep 13:155–162PubMedPubMedCentralCrossRef

18.

Hart PA, Bellin MD, Andersen DK et al (2016) Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol 1:226–237PubMedPubMedCentralCrossRef

19.

Hart PA, Bradley D, Conwell DL et al (2021) Diabetes following acute pancreatitis. Lancet Gastroenterol Hepatol 6:668–675PubMedCrossRef

20.

Heisel O, Heisel R, Balshaw R et al (2004) New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant 4:583–595PubMedCrossRef

21.

Hsiang JC, Gane EJ, Bai WW et al (2015) Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patients. J Gastroenterol Hepatol 30:591–599PubMedCrossRef

22.

Hussain MA, Bin-Ayeed SA, Saeed OQ et al (2016) Impact of diabetes on carotid artery revascularization. J Vasc Surg 63:1099–1107.e4PubMedCrossRef

23.

Jones CE, Graham LA, Morris MS et al (2017) Association between preoperative hemoglobin A1c levels, postoperative hyperglycemia, and readmissions following gastrointestinal surgery. JAMA Surg 152:1031–1038PubMedPubMedCentralCrossRef

24.

Karimian N, Niculiseanu P, Amar-Zifkin A et al (2018) Association of elevated pre-operative hemoglobin A1c and post-operative complications in non-diabetic patients: a systematic review. World J Surg 42:61–72PubMedCrossRef

25.

Kellerer M, Stalla G, Hrabé De Angelis M (2020) Ausbildungskapazitäten im Bereich Diabetologie und Endokrinologie müssen ausgebaut werden. In: Kellerer M, Bitzer B, Kröger J, Mattig-Fabian N (Hrsg) Deutscher Gesundheitsbericht Diabetes 2021. Die Bestandsaufnahme. Kirchheim, Mainz, S 225–230

26.

Khunti K, Del Prato S, Mathieu C et al (2021) COVID-19, hyperglycemia, and new-onset diabetes. Diabetes Care 44:2645–2655PubMedPubMedCentralCrossRef

27.

Kim HJ, Jung SH, Kim JJ et al (2017) New-onset diabetes mellitus after heart transplantation-incidence, risk factors and impact on clinical outcome. Circ J 81:806–814PubMedCrossRef

28.

Korytkowski MT, Salata RJ, Koerbel GL et al (2009) Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care 32:594–596PubMedPubMedCentralCrossRef

29.

Kotagal M, Symons RG, Hirsch IB et al (2015) Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg 261:97–103PubMedCrossRef

30.

Kotha S, Lawendy B, Asim S et al (2021) Impact of immunosuppression on incidence of post-transplant diabetes mellitus in solid organ transplant recipients: systematic review and meta-analysis. World J Transplant 11:432–442PubMedPubMedCentralCrossRef

31.

Kotwal A, Cheung YM, Cromwell G et al (2021) Patient-centered diabetes care of cancer patients. Curr Diab Rep 21:62PubMedCrossRef

32.

Kramer JR, Natarajan Y, Dai J et al (2021) Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease. Hepatology. https://doi.org/10.1002/hep.32244CrossRefPubMed

33.

Krinsley JS, Rule P, Pappy L et al (2020) The interaction of acute and chronic glycemia on the relationship of hyperglycemia, hypoglycemia, and glucose variability to mortality in the critically ill. Crit Care Med 48:1744–1751PubMedCrossRef

34.

Kufeldt J, Kovarova M, Adolph M et al (2018) Prevalence and distribution of diabetes mellitus in a maximum care hospital: urgent need for HbA1c-screening. Exp Clin Endocrinol Diabetes 126:123–129PubMedCrossRef

35.

Kuhl J, Sartipy U, Eliasson B et al (2016) Relationship between preoperative hemoglobin A1c levels and long-term mortality after coronary artery bypass grafting in patients with type 2 diabetes mellitus. Int J Cardiol 202:291–296PubMedCrossRef

36.

Kwon S, Thompson R, Dellinger P et al (2013) Importance of perioperative glycemic control in general surgery: a report from the surgical care and outcomes assessment program. Ann Surg 257:8–14PubMedCrossRef

37.

Lawendy B, Srinathan S, Kotha S et al (2021) Systematic review and meta-analysis of post-transplant diabetes mellitus in liver transplant recipients. Clin Transplant 35:e14340PubMedCrossRef

38.

Li DW, Lu TF, Hua XW et al (2015) Risk factors for new onset diabetes mellitus after liver transplantation: a meta-analysis. World J Gastroenterol 21:6329–6340PubMedPubMedCentralCrossRef

39.

Lin LY, Lin HC, Lee PC et al (2007) Hyperglycemia correlates with outcomes in patients receiving total parenteral nutrition. Am J Med Sci 333:261–265PubMedCrossRef

40.

Lin S, He W, Zeng M (2020) Association of diabetes and admission blood glucose levels with short-term outcomes in patients with critical illnesses. J Inflamm Res 13:1151–1166PubMedPubMedCentralCrossRef

41.

Liu XX, Zhu XM, Miao Q et al (2014) Hyperglycemia induced by glucocorticoids in nondiabetic patients: a meta-analysis. Ann Nutr Metab 65:324–332PubMedCrossRef

42.

Luijks H, Schermer T, Bor H et al (2012) Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study. BMC Med 10:128PubMedPubMedCentralCrossRef

43.

Mantovani A, Byrne CD, Targher G (2022) Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide‑1 receptor agonists, or sodium-glucose cotransporter‑2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review. Lancet Gastroenterol Hepatol 7:367–378PubMedCrossRef

44.

Mantovani A, Petracca G, Beatrice G et al (2021) Glucagon-like peptide‑1 receptor agonists for treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: an updated meta-analysis of randomized controlled trials. Metabolites 11(2):73. https://doi.org/10.3390/metabo11020073CrossRefPubMedPubMedCentral

45.

Mantovani A, Petracca G, Beatrice G et al (2021) Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. Gut 70:962–969PubMedCrossRef

46.

Martin ET, Kaye KS, Knott C et al (2016) Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 37:88–99PubMedCrossRef

47.

Maxwell DW, Jajja MR, Galindo RJ et al (2020) Post-pancreatectomy diabetes index: a validated score predicting diabetes development after major pancreatectomy. J Am Coll Surg 230:393–402.e3PubMedCrossRef

48.

Mcalister FA, Majumdar SR, Blitz S et al (2005) The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 28:810–815PubMedCrossRef

49.

Miko A, Farkas N, Garami A et al (2018) Preexisting diabetes elevates risk of local and systemic complications in acute pancreatitis: systematic review and meta-analysis. Pancreas 47:917–923PubMedPubMedCentralCrossRef

50.

Muller-Wieland D, Merkel M, Hamann A et al (2018) Survey to estimate the prevalence of type 2 diabetes mellitus in hospital patients in Germany by systematic HbA1c measurement upon admission. Int J Clin Pract 72:e13273PubMedCrossRef

51.

Neu A, Kröger J (2021) Deutscher Gesundheitsbericht Diabetes 2022. Die Bestandsaufnahme. Verlag Kirchheim + Co, Mainz

52.

Ojo O, Brooke J (2014) Evaluation of the role of enteral nutrition in managing patients with diabetes: a systematic review. Nutrients 6:5142–5152PubMedPubMedCentralCrossRef

53.

Olariu E, Pooley N, Danel A et al (2018) A systematic scoping review on the consequences of stress-related hyperglycaemia. PLoS ONE 13:e194952PubMedPubMedCentralCrossRef

54.

Paragomi P, Papachristou GI, Jeong K et al (2022) The relationship between pre-existing diabetes mellitus and the severity of acute pancreatitis: report from a large international registry. Pancreatology 22(1):85–91. https://doi.org/10.1016/j.pan.2021.10.001CrossRefPubMed

55.

Park J, Oh AR, Lee SH et al (2021) Associations between preoperative glucose and hemoglobin A1c level and myocardial injury after noncardiac surgery. J Am Heart Assoc 10:e19216PubMedPubMedCentralCrossRef

56.

Pearson-Stuttard J, Buckley J, Cicek M et al (2021) The changing nature of mortality and morbidity in patients with diabetes. Endocrinol Metab Clin North Am 50:357–368PubMedCrossRef

57.

Petrov MS (2021) DIAGNOSIS OF ENDOCRINE DISEASE: post-pancreatitis diabetes mellitus: prime time for secondary disease. Eur J Endocrinol 184:R137–R149PubMedCrossRef

58.

Piette JD, Kerr EA (2006) The impact of comorbid chronic conditions on diabetes care. Diabetes Care 29:725–731PubMedCrossRef

59.

Richardson A, Park WG (2021) Acute pancreatitis and diabetes mellitus: a review. Korean J Intern Med 36:15–24PubMedCrossRef

60.

Rubin DJ, Shah AA (2021) Predicting and preventing acute care re-utilization by patients with diabetes. Curr Diab Rep 21:34PubMedPubMedCentralCrossRef

61.

Safieddine B, Sperlich S, Epping J et al (2021) Development of comorbidities in type 2 diabetes between 2005 and 2017 using German claims data. Sci Rep 11:11149PubMedPubMedCentralCrossRef

62.

Sharma A, Chari ST (2018) Pancreatic cancer and diabetes mellitus. Curr Treat Options Gastroenterol 16:466–478PubMedPubMedCentralCrossRef

63.

Singh AK, Singh R (2020) Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19. Diabetes Res Clin Pract 167:108382PubMedPubMedCentralCrossRef

64.

Stepanova M, Clement S, Wong R et al (2017) Patients with diabetes and chronic liver disease are at increased risk for overall mortality: a population study from the United States. Clin Diabetes 35:79–83PubMedPubMedCentralCrossRef

65.

Suh S, Kim KW (2019) Diabetes and cancer: cancer should be screened in routine diabetes assessment. Diabetes Metab J 43:733–743PubMedPubMedCentralCrossRef

66.

Tamayo T, Brinks R, Hoyer A et al (2016) The prevalence and incidence of diabetes in Germany. Dtsch Arztebl Int 113:177–182PubMedPubMedCentral

67.

Tan DJH, Yaow CYL, Mok HT et al (2021) The influence of diabetes on postoperative complications following colorectal surgery. Tech Coloproctol 25:267–278PubMedPubMedCentralCrossRef

68.

Tancredi M, Rosengren A, Svensson AM et al (2015) Excess mortality among persons with type 2 diabetes. N Engl J Med 373:1720–1732PubMedCrossRef

69.

Tsilidis KK, Kasimis JC, Lopez DS et al (2015) Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 350:g7607PubMedCrossRef

70.

van den Boom W, Schroeder RA, Manning MW et al (2018) Effect of A1C and glucose on postoperative mortality in noncardiac and cardiac surgeries. Diabetes Care 41:782–788PubMedCrossRef

71.

Vennard KC, Selen DJ, Gilbert MP (2018) The management of hyperglycemia in noncritically ill hospitalized patients treated with continuous enteral or parenteral nutrition. Endocr Pract 24:900–906PubMedCrossRef

72.

Wan G, Sun X, Li F et al (2018) Survival benefit of metformin adjuvant treatment for pancreatic cancer patients: a systematic review and meta-analysis. Cell Physiol Biochem 49:837–847PubMedCrossRef

73.

Wang W, Chen W, Liu Y et al (2021) Blood glucose levels and mortality in patients with sepsis: dose-response analysis of observational studies. J Intensive Care Med 36:182–190PubMedCrossRef

74.

Wild SH, Walker JJ, Morling JR et al (2018) Cardiovascular disease, cancer, and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission. Diabetes Care 41:341–347PubMedCrossRef

75.

Wojciechowska J, Krajewski W, Bolanowski M et al (2016) Diabetes and cancer: a review of current knowledge. Exp Clin Endocrinol Diabetes 124:263–275PubMedCrossRef

76.

Worley N, Buza J, Jalai CM et al (2017) Diabetes as an independent predictor for extended length of hospital stay and increased adverse post-operative events in patients treated surgically for cervical spondylotic myelopathy. Int J Spine Surg 11:10PubMedPubMedCentralCrossRef

77.

Wu J, Mackie SL, Pujades-Rodriguez M (2020) Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis. BMJ Open Diabetes Res Care 8(1):e1220. https://doi.org/10.1136/bmjdrc-2020-001220CrossRefPubMedPubMedCentral

78.

Wu L, Nahm CB, Jamieson NB et al (2020) Risk factors for development of diabetes mellitus (type 3c) after partial pancreatectomy: a systematic review. Clin Endocrinol (Oxf) 92:396–406CrossRef

79.

Wu L, Zhu J, Prokop LJ et al (2015) Pharmacologic therapy of diabetes and overall cancer risk and mortality: a meta-analysis of 265 studies. Sci Rep 5:10147PubMedPubMedCentralCrossRef

80.

Xia M, Yang H, Tong X et al (2021) Risk factors for new-onset diabetes mellitus after kidney transplantation: a systematic review and meta-analysis. J Diabetes Investig 12:109–122PubMedCrossRef

81.

Xu H, Zhang L, Kang H et al (2021) Metabolomics identifies biomarker signatures to differentiate pancreatic cancer from type 2 diabetes mellitus in early diagnosis. Int J Endocrinol 2021:9990768PubMedPubMedCentralCrossRef

82.

Yao S, Li J, Fan X et al (2018) The effect of selective serotonin re-uptake inhibitors on risk of type II diabetes mellitus and acute pancreatitis: a meta-analysis. Biosci Rep 38(5):BSR20180967PubMedPubMedCentralCrossRef

83.

Yim C, Mansell K, Hussein N et al (2021) Current cancer therapies and their influence on glucose control. World J Diabetes 12:1010–1025PubMedPubMedCentralCrossRef

84.

Yin M, Zhou J, Gorak EJ et al (2013) Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis. Oncologist 18:1248–1255PubMedPubMedCentralCrossRef

85.

Younossi ZM, Golabi P, de Avila L et al (2019) The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol 71:793–801PubMedCrossRef

86.

Yu J, Sun R, Han X et al (2020) New-onset diabetes mellitus after distal pancreatectomy: a systematic review and meta-analysis. J Laparoendosc Adv Surg Tech A 30:1215–1222PubMedCrossRef

87.

Zghebi SS, Steinke DT, Rutter MK et al (2020) Eleven-year multimorbidity burden among 637 255 people with and without type 2 diabetes: a population-based study using primary care and linked hospitalisation data. BMJ Open 10:e33866PubMedCrossRef

88.

Zhang J, Ma J, Guo L et al (2020) Survival benefit of metformin use for pancreatic cancer patients who underwent pancreatectomy: results from a meta-analysis. Front Med (Lausanne) 7:282CrossRef

89.

Zhao Y, Xing H, Wang X et al (2019) Management of diabetes mellitus in patients with chronic liver diseases. J Diabetes Res 2019:6430486PubMedPubMedCentral

90.

Zhi M, Zhu X, Lugea A et al (2019) Incidence of new onset diabetes mellitus secondary to acute pancreatitis: a systematic review and meta-analysis. Front Physiol 10:637PubMedPubMedCentralCrossRef

91.

Zhou PT, Li B, Liu FR et al (2017) Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis. Oncotarget 8:25242–25250PubMedPubMedCentralCrossRef

92.

Zhu X, Liu D, Wei Q et al (2019) New-onset diabetes mellitus after chronic pancreatitis diagnosis: a systematic review and meta-analysis. Pancreas 48:868–875PubMedCrossRef

Titel: Stationäre Patienten mit der Nebendiagnose Diabetes mellitus: klinische Relevanz
verfasst von: Prof. Dr. med. Christian Jenssen
Dr. med. Cristine Pietsch
Publikationsdatum: 27.04.2022
Verlag: Springer Medizin
Schlagwörter: Diabetes mellitus
Hyperglykämie
Erschienen in: Die Diabetologie / Ausgabe 4/2022
Print ISSN: 2731-7447
Elektronische ISSN: 2731-7455
DOI: https://doi.org/10.1007/s11428-022-00897-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Stationäre Patienten mit der Nebendiagnose Diabetes mellitus: klinische Relevanz

Zusammenfassung

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2022

DDG Praxisempfehlungen: Empfehlungen zur Ernährung von Personen mit Diabetes mellitus Typ 2

Prävalenz eines Vitamin-B12-Mangels bei Metformintherapie

Eine frühzeitige Diabetesdiagnose im Krankenhaus – eine unterschätzte Möglichkeit

Leitlinien in der Diabetologie – Bedeutung im Praxisalltag und in der Gesundheitspolitik

Der Diabetologe wird zu Die Diabetologie

Empfehlungen zur Ernährung von Personen mit Diabetes mellitus Typ 1

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin